. Clonogenic Assay. Clonogenic assay performed in cells cultured with 2.5 µ M (PLC/PRF/5) or 1 µ M (HepG2) Sorafenib (S), 1 µ M (PLC/PRF/5) or 0.1 µ M (HepG2) Regorafenib (R), 3 µ M GSK1838705A (GSK) and 400 µ M Ramucirumab (Ram) alone or in combination. IGF1 75 ng/mL and VEGF 20 ng/mL recombinant molecules were used as single treatment. The average value of number of colonies derived from three independent experiments, the p value and the percentage decreases for the interest group are reported. 
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